Recombinant HBsAg have hybrid particles, the morphological properties of the HBsAg antigen, and an immunogenic sequence contained induces neutralizing antibodies against HIV, or which is recognized by these antibodies, nucleotides sequences encoding such particles, and vaccines containing them